R

Reata Pharmaceuticals, Inc.

Pharmaceutical Manufacturing · United States · 500 employees

7 Decision makers
500 Employees
$23M Revenue
2002 Founded

Organizational Chart of Reata Pharmaceuticals, Inc.

Roles identified within Reata Pharmaceuticals, Inc.'s leadership team, from public professional data, updated 18 Oct 2026.

Department

Reata Pharmaceuticals, Inc.'s Full Organizational Chart

Loading…

Get their contacts on Zeliq →

Job title Department People Action

Decision makers at Reata Pharmaceuticals, Inc. by function

General management

Other functions

See all Reata Pharmaceuticals, Inc. contacts on Zeliq

Decision makers at Reata Pharmaceuticals, Inc.

7 identified 1 C-Level 3 VP 3 Directors
See them on Zeliq →

Funding and news at Reata Pharmaceuticals, Inc.

Funding

Last round Other · $275M
Total funding $2.0B (17 rounds)
Corporate Round N/A Jan 2002
Series A $2M Sep 2002
Series B $4M Sep 2003
Series C $12M Nov 2004
Series D $7M Jun 2006
Series E $25M Jul 2007
Series F $31M Dec 2008
Venture Round $17M Sep 2009
Venture Round $2M Feb 2010
Venture Round $78M Jul 2010
Venture Round $300M Jul 2011
Post-IPO Debt $35M Apr 2017
Post-IPO Equity $116M Jul 2017
Post-IPO Equity $248M Jul 2018
Post-IPO Equity $505M Nov 2019
Post-IPO Equity $350M Jun 2020
Post-IPO Debt $275M May 2023

Team Structure headcount by department

Medical
13
Research
6
Project Management
5
Operations
3
Other
3
Finance
2
General Management
2
Legal
2

How to prospect Reata Pharmaceuticals, Inc.'s departments

Medical

The company's largest department, with 13 people. Medical teams trust peer references: name comparable organisations you already serve.

Research

With 6 people, this is the organisation's second pillar. Data quality and reproducibility are core concerns: a strong angle if your offer touches either.

Project Management

A team of 5 people. These profiles own delivery: anything that de-risks a milestone gets their attention.

Operations

This department counts 3 people. Pitch measurable time savings and error reduction: the metrics this function is judged on.

Other

3 people work in this department. Hard to read from the outside: use a first exchange to map who does what before pushing an offer.

Finance

A team of 2 people. Timing matters here: approach them around budget planning cycles, when arbitrations are actually open.

Try the Zeliq email finder demo →

FAQ Reata Pharmaceuticals, Inc.

Who runs Reata Pharmaceuticals, Inc.?

The highest-ranking leadership role identified at Reata Pharmaceuticals, Inc. is “Senior Vice President, Chief Scientific Officer & Founding Scientist”, based on public data updated 18 Oct 2026.

How many decision makers does Reata Pharmaceuticals, Inc. have?

7 decision makers identified, including 1 at executive level.

How do I contact a decision maker at Reata Pharmaceuticals, Inc.?

Verified emails and phone numbers are available in Zeliq, with free credits at sign-up.

Companies similar to Reata Pharmaceuticals, Inc.

More companies to explore

Pharmaceutical Manufacturing · United States

All Pharmaceutical Manufacturing companies in United States →

About Reata Pharmaceuticals, Inc.

Reata Pharmaceuticals, Inc. is a Pharmaceutical Manufacturing company, operating from United States. The company was founded in 2002 and employs approximately 500 people. Reata Pharmaceuticals, Inc. belongs to the Manufacturing sector, with a specific positioning on Pharmaceutical Manufacturing. Reata Pharmaceuticals, Inc. sells primarily to other businesses (B2B) rather than to end consumers. Reata Pharmaceuticals, Inc. has raised funding across 17 rounds totalling $2.0B. Its estimated yearly revenue stands at about $23M. Use this page to review Reata Pharmaceuticals, Inc.'s industry, headcount, location and hiring signals, and to reach verified B2B contacts before your next outreach.

Activity & Market

Reata Pharmaceuticals, Inc. is positioned on the Pharmaceutical Manufacturing segment, within the Manufacturing sector. As a B2B company, Reata Pharmaceuticals, Inc. primarily serves business clients and professional organisations. The company is categorised as “Public company”.